PHAXIAM Therapeutics S. A. , a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States.
Phaxiam Therapeutics Sa stock last closed at $5.19, up 9.49% from the previous day, and has decreased 3.89% in one year. It has overperformed other stocks in the Biotechnology industry by 0.29 percentage points. Phaxiam Therapeutics Sa stock is currently +73% from its 52-week low of $3.00, and -62.93% from its 52-week high of $14.00.
As of Sep 29, 2023, there are 3.28M shares of PHXM outstanding. The market cap of PHXM is $17.05M. In the past 24 hours, 25,455 PHXM shares were traded.
You need an online brokerage account to access the NASDAQ market and buy PHXM shares.
We believe that eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountNow that you've chosen your brokerage, it's time to fill out some personal information so you can invest in PHXM stock today.
Now that you have created your account on our top ranked stock market app, your next step is to transfer the money for your investment:
Watch this video walkthrough for more details transferring money into your new brokerage account.
After you have figured out the best place to buy Phaxiam Therapeutics Sa stock, it's absolutely critical to research their stock prior to investing, so you truly comprehend the risk and upside.
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on PHXM's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge PHXM's fair value.
Using relative valuations measures:
You can do more valuation analysis on PHXM's stock here.
Last year, PHXM revenue was $6.35M. During the last 4 year, PHXM's revenue has grown by 2.92% per year. This was slower than the Biotechnology industry average of 108.28%.
Learn more about PHXM's earnings and revenue performance here.
In the last 12 months, executives and large shareholders at PHXM have not bought or sold any shares.
Dig into more about who owns PHXM stock here.
No, Phaxiam Therapeutics Sa doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two main order types:
Press the Open Trade button and eToro will place the order.
If you need additional help with investing in stocks on eToro, click the helpful video below:
Now that you own some PHXM shares, you'll want to keep up with your company.
Start a watchlist to track the latest developments regarding your PHXM stock.
To summarize, here are the 6 steps you need to take to buy Phaxiam Therapeutics Sa stock right now:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep track of your investment in Phaxiam Therapeutics Sa, click the button below.